Leukotriene receptor antagonists: their therapeutic role in children with asthma

Contents

Key Points

Introduction

Diagnostic considerations in young children

Rationale for leukotriene antagonism in childhood asthma

Clinical evidence for montelukast use in children

Preventive treatment in children

Other potential roles of LTRAs

Acknowledgements

References

Publication

Published by National Asthma Council Australia Ltd.
ACN 058 044 634
Suite 104, Level 1
153-161 Park Street
South Melbourne VIC 3205
Australia
Tel: (+61) 3 9929 4333    Email: nac@nationalasthma.org.au
Fax: (+61) 3 9929 4300    Website: www.nationalasthma.org.au

Copyright
© 2007 National Asthma Council Australia Ltd

Disclaimer

Although all care has been taken, this information paper is a general guide only, which is not intended to be a substitute for individual medical advice/treatment. The National Asthma Council Australia expressly disclaims all responsibility (including for negligence) for any loss, damage or personal injury resulting from reliance on the information contained herein.

Suggested citation:

National Asthma Council Australia. Leukotriene receptor antagonists: their therapeutic role in children with asthma. Revised June 2007. Melbourne: National Asthma Council Australia, 2007.

Proudly supported by Merck Sharp & Dohme

This information paper was supported by an unrestricted educational grant from Merck Sharp & Dohme (Australia) Pty Ltd. National Asthma Council Australia retained editorial control.